151 related articles for article (PubMed ID: 20975424)
1. Disease-modifying antirheumatic drugs.
Belavic J
Nursing; 2010 Nov; 40(11):20. PubMed ID: 20975424
[No Abstract] [Full Text] [Related]
2. Pregnancy and rheumatic diseases.
Malviya AN
J Assoc Physicians India; 1994 Feb; 42(2):178. PubMed ID: 7860501
[No Abstract] [Full Text] [Related]
3. Rheumatology. 3. Modern drug therapies and current guidelines in rheumatology nursing.
Hill J; Reay N
Nurs Times; 2002 Mar 7-13; 98(10):41-4. PubMed ID: 11921625
[No Abstract] [Full Text] [Related]
4. Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
Weisman MH
Rheum Dis Clin North Am; 2012 Nov; 38(4):ix-x. PubMed ID: 23137584
[No Abstract] [Full Text] [Related]
5. [Unwanted reactions to modifying antirheumatic drugs].
Evsikova MD; Muraviev IuV
Ter Arkh; 2005; 77(5):72-4. PubMed ID: 15989010
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for use of antirheumatic drugs.
Russell AS; Darmawan J; Scott DL; Brooks PM; Hubscher O
J Rheumatol Suppl; 1994 Sep; 41():79-81. PubMed ID: 7799391
[TBL] [Abstract][Full Text] [Related]
7. Disease modifying antirheumatic drugs and pregnancy.
Uhl K; Kennedy DL; Gilliland WR
J Rheumatol; 2004 Feb; 31(2):400-1; author reply 401-2. PubMed ID: 14760818
[No Abstract] [Full Text] [Related]
8. TPMT testing in rheumatology: any better than routine monitoring?
Payne K; Newman W; Fargher E; Tricker K; Bruce IN; Ollier WE
Rheumatology (Oxford); 2007 May; 46(5):727-9. PubMed ID: 17255139
[No Abstract] [Full Text] [Related]
9. The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelines.
Deighton C; Gadsby K
Musculoskeletal Care; 2006 Sep; 4(3):174-81. PubMed ID: 17042028
[No Abstract] [Full Text] [Related]
10. Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease.
Moitra RK; Ledingham JM; Hull RG; McCrae FC; Thomas AL; Shaban R; Mackay KR
Rheumatology (Oxford); 2005 Feb; 44(2):256-7. PubMed ID: 15637036
[No Abstract] [Full Text] [Related]
11. [Biosimilars].
Burmester GR; Müller-Ladner U
Z Rheumatol; 2015 Oct; 74(8):670-1. PubMed ID: 26450433
[No Abstract] [Full Text] [Related]
12. [Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases].
Falcão S; Mourão AF; Pimentão JB; Branco JC
Acta Reumatol Port; 2007; 32(4):323-31. PubMed ID: 18159198
[TBL] [Abstract][Full Text] [Related]
13. Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?
Wendling D; Di Martino V; Herbein G
J Rheumatol; 2009 Jun; 36(6):1107-8. PubMed ID: 19509089
[No Abstract] [Full Text] [Related]
14. [Rheumatism in elderly patients].
Wollenhaupt J; Zink A
Z Rheumatol; 2014 Apr; 73(3):215-6. PubMed ID: 27039909
[No Abstract] [Full Text] [Related]
15. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
Anić B; Cikes N
Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
[TBL] [Abstract][Full Text] [Related]
16. Introduction to special section: drug safety in the rheumatic diseases.
Lovell D
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):747-8. PubMed ID: 20499388
[No Abstract] [Full Text] [Related]
17. Anti-cytokine antibodies for rheumatic diseases.
Atzeni F; Sarzi-Puttini P
Curr Opin Investig Drugs; 2009 Nov; 10(11):1204-11. PubMed ID: 19876788
[TBL] [Abstract][Full Text] [Related]
18. [Rheumatic collagen diseases and drug-induced kidney disorders].
Yamada A
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Jun; 25(3):255-62. PubMed ID: 16646161
[No Abstract] [Full Text] [Related]
19. Drug therapy in adolescents with rheumatic diseases.
Schaller JG
Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):194S-195S. PubMed ID: 9385680
[No Abstract] [Full Text] [Related]
20. The use of methotrexate in childhood rheumatic diseases.
Wallace CA
Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
